Encore Preparing For Stimulan Bone Graft Substitute Launch In U.S.
This article was originally published in The Gray Sheet
Executive Summary
Encore Medical Corp.' s principle operating subsidiary, Encore Orthopedics, is poised to enter the bone void filler niche of the orthopedics products market with the Stimulan bone graft substitute.